Pa tsiku loyamba, Februray, Shanghai Chuangkun Biotechnology Co., Ltd. adalandira satifiketi yachiwiri yolembetsa ku Thailand FDA ya zida zodziwira za TB/NTM-DNA, motsogozedwa ndi zida za PCR zamtundu 15 zamtundu wa HPV mwezi watha.amene analengeza kuti mankhwala Chuangkun Biotech aloledwa ndi Thailand FDA, kuwongolera zinthu zodzipangira okha, komanso kupereka thandizo lamphamvu Chuangkun Biotech kupititsa patsogolo msika mayiko.
Padziko lonse lapansi anthu pafupifupi 10.6 miliyoni adadwala TB yofalitsidwa ndi WHO mu 2021. Kuwonjezeka kwa 4.5% kuposa chaka cha 2020.Panthawiyi, anthu 1.6 miliyoni adamwalira ndi chifuwa chachikulu chaka chatha (kuphatikiza 6.7% anali m'gulu la anthu omwe ali ndi kachilombo ka HIV). .Pamalo, ambiri TB odwala 2021 anali WHO zigawo South-East Asia (45%), Africa (23%) ndi Western Pacific (18%), ndi magawo ang'onoang'ono Eastern Mediterranean (8.1%), Americas. (2.9%) ndi Europe (2.2%).Poganizira za Mliri wa COVID-19, kupewa ndi kuwongolera chifuwa chachikulu kumakhala kovutirapo pa Plan of Termination of TB ya WHO.
Zida zodziwira za TB/NTM-DNA za CHUANGKUN Biotech zidapangidwa ndi njira ya lyophilization Njirayi ithetsa kuipa kwanthawi yayitali kwa zida zodziwira za PCR, kumabweretsanso kulondola kwabwino komanso zotsatira zatsatanetsatane kwambiri kuposa momwe mungagwiritsire ntchito.
Shanghai Chuangkun Biotechnology Co., Ltd. idalandira satifiketi yachiwiri yolembetsa ku Thailand FDA ya zida zodziwira za TB/NTM-DNA, zomwe zikuwonetsa kuvomerezedwa ndi Thailand FDA.Chuangkun Biotech itenga nawo gawo popewa chifuwa chachikulu cha TB ndikuwongolera mwamphamvu.
Nthawi yotumiza: Feb-02-2023